Sign in

CIK 0001806310 · Non-accelerated filer<br>Smaller reporting company

Taysha Gene Therapies, Inc.

Sign in to watch
Ticker
TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843199512
Phone
(214) 612-0000
Business address
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
  1. S-3ASR Offering Registration Statement
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. DEFR14A Other DEFR14A
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. EFFECT Other Notice of Effectiveness
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. DEFA14A Proxy Proxy Materials
  18. ARS Other Annual Report to Security Holders
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 2 of 4 · 67 filings